Optimizing study design in LPS challenge studies for quantifying drug induced inhibition of TNFα response: Did we miss the prime time?
Authors:
Open Access
- 9 July 2022
- journal article
- research article
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 176, 106256
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- How to calculate sample size in animal studies?Journal of Pharmacology and Pharmacotherapeutics, 2013
- PopED: An extended, parallelized, nonlinear mixed effects models optimal design toolComputer Methods and Programs in Biomedicine, 2012
- Pharmacokinetic-Pharmacodynamic Modeling of Methylxanthine Derivatives in Mice Challenged with High-Dose LipopolysaccharidePharmacology, 2010
- Simultaneous optimal experimental design on dose and sample timesJournal of Pharmacokinetics and Pharmacodynamics, 2009
- Origin and physiological roles of inflammationNature, 2008
- Implementation of a transit compartment model for describing drug absorption in pharmacokinetic studiesJournal of Pharmacokinetics and Pharmacodynamics, 2007
- A rat pharmacokinetic/pharmacodynamic model for assessment of lipopolysaccharide-induced tumor necrosis factor-alpha productionJournal of Pharmacological and Toxicological Methods, 2007
- Pharmacodynamic interactions between recombinant mouse interleukin‐10 and prednisolone using a mouse endotoxemia modelJournal of Pharmaceutical Sciences, 2005
- poped, a software for optimal experiment design in population kineticsComputer Methods and Programs in Biomedicine, 2004
- Anti-TNF-α therapies: the next generationNature Reviews Drug Discovery, 2003